Raj Parekh is a General Partner at Advent Life Sciences LLP, which he joined in 2006.
During his academic career at the University of Oxford, he co-founded Oxford GlycoSciences plc, where he served as Chief Scientific Officer and CEO from 1988 until its acquisition by Celltech Group plc (now UCB SA) in 2003.
He has founded and served on the boards of several life sciences companies in both the United States and Europe, including AMT Holding NV (formerly uniQure), Arrakis Inc., Aura Inc., Avila Therapeutics Inc., Biocartis NV, EUSA Pharma Limited, and Galápagos NV, where he has been Chairman of the Board since 2004.
Raj holds a Master’s degree in Biochemistry and a Ph.D. in Molecular Medicine from the University of Oxford, where he also held research and teaching positions.
Preguntar a ChatGPT
